META-ANALYSIS FOR THE EVALUATION OF MULTIPLE SURROGATE ENDPOINTS

被引：0
|
作者：
Bujkiewicz, S. [1 ]
Spata, E. [1 ]
Thompson, J. R. [1 ]
Abrams, K. [1 ]
机构：
[1] Univ Leicester, Leicester, Leics, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.141
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM75
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [21] Evaluation of potential surrogate endpoints for prediction of overall survival in patients with castration-resistant prostate cancer: trial-level meta-analysis
    Wenjun Chen
    Liang Li
    Shuangmin Ji
    Xuyang Song
    Wei Lu
    Tianyan Zhou
    European Journal of Clinical Pharmacology, 2019, 75 : 1521 - 1532
  • [22] Evaluation of potential surrogate endpoints for prediction of overall survival in patients with castration-resistant prostate cancer: trial-level meta-analysis
    Chen, Wenjun
    Li, Liang
    Ji, Shuangmin
    Song, Xuyang
    Lu, Wei
    Zhou, Tianyan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (11) : 1521 - 1532
  • [23] Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis
    Ramesh, Sharanya
    Mann, Michelle C.
    Holroyd-Leduc, Jayna M.
    Wilton, Stephen B.
    James, Matthew T.
    Seely, Ellen W.
    Ahmed, Sofia B.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (09): : 1028 - 1037
  • [24] MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
    Sormani, Maria Pia
    Bruzzi, Paolo
    LANCET NEUROLOGY, 2013, 12 (07): : 669 - 676
  • [25] Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis
    Ntellas, Panagiotis
    Perivoliotis, Konstantinos
    Dadouli, Katerina
    Koukoulis, Georgios K.
    Ioannou, Maria
    ACTA HAEMATOLOGICA, 2017, 138 (02) : 77 - 84
  • [26] Surrogate endpoints for overall survival in randomized controlled trials evaluating adjuvant treatment for breast cancer: A meta-analysis
    Savina, M.
    Jacot, W.
    Mathoulin-Pelissier, S.
    Laghzali, Y.
    Bellera, C.
    Gourgou, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Optimal candidates and surrogate endpoints for HAIC versus Sorafenib in hepatocellular carcinoma: an updated systematic review and meta-analysis
    Si, Tengfei
    Shao, Qing
    Jassem, Wayel
    Ma, Yun
    Heaton, Nigel
    INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) : 1203 - 1213
  • [28] Surrogate endpoints for overall survival in combined chemotherapy and radiotherapy trials in nasopharyngeal carcinoma: Meta-analysis of randomised controlled trials
    Chen, Yu-Pei
    Sun, Ying
    Chen, Lei
    Mao, Yan-Ping
    Tang, Ling-Long
    Li, Wen-Fei
    Liu, Xu
    Zhang, Wen-Na
    Zhou, Guan-Qun
    Guo, Rui
    Lin, Ai-Hua
    Ma, Jun
    RADIOTHERAPY AND ONCOLOGY, 2015, 116 (02) : 157 - 166
  • [29] ASSOCIATION OF SURROGATE ENDPOINTS (SERUM PARATHYROID HORMONE, CALCIUM AND PHOSPHORUS) WITH MORTALITY IN CHRONIC KIDNEY DISEASE TRIALS: A META-ANALYSIS
    Palmer, Suetonia
    Teixeira-Pinto, Armando
    Saglimbene, Valeria
    Macaskill, Petra
    Craig, Jonathan
    Strippoli, Giovanni
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 390 - 391
  • [30] Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis
    Sala, Isabella
    Pagan, Eleonora
    Pala, Laura
    Oriecuia, Chiara
    Musca, Marco
    Specchia, Claudia
    De Pas, Tommaso
    Cortes, Javier
    Giaccone, Giuseppe
    Postow, Michael
    Gelber, Richard D.
    Bagnardi, Vincenzo
    Conforti, Fabio
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345